Basic Information
TRIMBOW PRESSURISED INHALATION SOLUTION 100/6/12.5 μg PER ACTUATION
AEROSOL, METERED
Regulatory Information
SIN15924P
April 2, 2020
Prescription Only
Therapeutic
RESPIRATORY (INHALATION)
August 10, 2023
June 3, 2025
XR03AL09
Company Information
Active Ingredients
Strength: 0.0125mg/actuation
Strength: 0.1mg/actuation
Strength: 0.006mg/actuation
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**4.1 Therapeutic indications** Maintenance treatment in adult patients with chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist (for effects on symptoms control and prevention of exacerbations see section 5.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).